Lexicon Pharmaceuticals LXRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $660.94M.
The official record: Lexicon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lexicon Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lexicon Pharmaceuticals's market capitalization?
- Lexicon Pharmaceuticals (LXRX) reported market capitalization of $660.94M in Q1 2026.
- How has Lexicon Pharmaceuticals's market capitalization changed year-over-year?
- Lexicon Pharmaceuticals's market capitalization increased by 296.8% year-over-year, from $166.58M to $660.94M.
- What is the long-term trend for Lexicon Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), Lexicon Pharmaceuticals's market capitalization has grown at a -3.9% compound annual growth rate (CAGR), from $509.22M to $417.91M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.